VIVAX | WPLCX | VIVAX / WPLCX | |
Total Expense Ratio | 0.17 | 2.54 | 7% |
Annual Report Gross Expense Ratio | 0.17 | 2.54 | 7% |
Fund Existence | 33 years | 12 years | - |
Gain YTD | -2.639 | -5.663 | 47% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 2000 | 150% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 191B | 21.5M | 888,372% |
Annual Yield % from dividends | 2.14 | 0.00 | - |
Returns for 1 year | 4.42 | 6.77 | 65% |
Returns for 3 years | 15.65 | 15.89 | 99% |
Returns for 5 years | 71.28 | 75.35 | 95% |
Returns for 10 years | 92.80 | 47.65 | 195% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JDEUX | 40.49 | 0.34 | +0.85% |
JPMorgan US Research Enhanced Equity R6 | |||
PGPCX | 24.18 | 0.15 | +0.62% |
George Putnam Balanced C | |||
MICIX | 8.64 | N/A | N/A |
Victory Trivalent Intl Fd-Core Eq I | |||
JETIX | 14.47 | -0.02 | -0.14% |
abrdn Focused Em Markets ex-China Instl | |||
VLEOX | 54.71 | -0.30 | -0.55% |
Value Line Small Cap Opportunities Inv |